Charles Schwab’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$697M Buy
2,120,239
+45,633
+2% +$16.4M 0.11% 156
2025
Q4
$729M Buy
2,074,606
+30,151
+1% +$11M 0.11% 149
2025
Q3
$756M Buy
2,044,455
+8,898
+0.4% +$3.44M 0.12% 142
2025
Q2
$805M Buy
2,035,557
+20,183
+1% +$7.55M 0.14% 129
2025
Q1
$750M Buy
2,015,374
+30,329
+2% +$11.5M 0.14% 129
2024
Q4
$715M Buy
1,985,045
+48,819
+3% +$18.1M 0.13% 127
2024
Q3
$699M Buy
1,936,226
+37,000
+2% +$12.8M 0.13% 131
2024
Q2
$646M Buy
1,899,226
+73,234
+4% +$24.8M 0.12% 142
2024
Q1
$653M Buy
1,825,992
+54,943
+3% +$18.5M 0.15% 119
2023
Q4
$530M Buy
1,771,049
+30,593
+2% +$8.59M 0.13% 126
2023
Q3
$476M Buy
1,740,456
+40,736
+2% +$11.7M 0.14% 125
2023
Q2
$519M Buy
1,699,720
+1,040
+0.1% +$300K 0.15% 120
2023
Q1
$485M Buy
1,698,680
+14,825
+0.9% +$3.93M 0.15% 123
2022
Q4
$412M Buy
1,683,855
+27,206
+2% +$6.17M 0.13% 144
2022
Q3
$336M Buy
1,656,649
+44,150
+3% +$9.29M 0.12% 158
2022
Q2
$321M Buy
1,612,499
+3,537
+0.2% +$831K 0.11% 168
2022
Q1
$430M Buy
1,608,962
+30,956
+2% +$8.01M 0.13% 140
2021
Q4
$422M Buy
1,578,006
+42,445
+3% +$11.1M 0.12% 146
2021
Q3
$405M Buy
1,535,561
+50,849
+3% +$13.6M 0.13% 137
2021
Q2
$386M Buy
1,484,712
+59,230
+4% +$15.1M 0.13% 140
2021
Q1
$347M Buy
1,425,482
+46,020
+3% +$11M 0.13% 140
2020
Q4
$338M Buy
1,379,462
+19,996
+1% +$4.53M 0.13% 141
2020
Q3
$283M Sell
1,359,466
-87,807
-6% -$17.1M 0.13% 144
2020
Q2
$261M Buy
1,447,273
+23,407
+2% +$4.32M 0.13% 149
2020
Q1
$237M Sell
1,423,866
-42,154
-3% -$8.24M 0.14% 145
2019
Q4
$308M Buy
1,466,020
+28,434
+2% +$5.9M 0.17% 111
2019
Q3
$311M Buy
1,437,586
+79,995
+6% +$17.2M 0.18% 104
2019
Q2
$279M Buy
1,357,591
+44,907
+3% +$8.58M 0.17% 109
2019
Q1
$259M Buy
1,312,684
+45,912
+4% +$8.26M 0.17% 113
2018
Q4
$199M Buy
1,266,772
+51,511
+4% +$8.62M 0.15% 121
2018
Q3
$216M Sell
1,215,261
-5,685
-0.5% -$970K 0.14% 132
2018
Q2
$206M Buy
1,220,946
+22,244
+2% +$3.74M 0.15% 128
2018
Q1
$193M Buy
1,198,702
+31,950
+3% +$5.15M 0.15% 129
2017
Q4
$181M Buy
1,166,752
+66,638
+6% +$10.2M 0.14% 139
2017
Q3
$156M Buy
1,100,114
+93,855
+9% +$13.5M 0.14% 141
2017
Q2
$140M Buy
1,006,259
+41,932
+4% +$5.75M 0.13% 151
2017
Q1
$127M Buy
964,327
+38,772
+4% +$4.9M 0.13% 152
2016
Q4
$111M Buy
925,555
+24,609
+3% +$2.83M 0.12% 154
2016
Q3
$105M Buy
900,946
+27,995
+3% +$3.26M 0.12% 151
2016
Q2
$105M Sell
872,951
-25,943
-3% -$2.9M 0.13% 145
2016
Q1
$96.4M Buy
898,894
+43,009
+5% +$4.24M 0.13% 150
2015
Q4
$79.5M Buy
855,885
+29,304
+4% +$2.8M 0.11% 176
2015
Q3
$77.8M Buy
826,581
+9,945
+1% +$985K 0.11% 170
2015
Q2
$77.9M Buy
816,636
+9,758
+1% +$925K 0.11% 184
2015
Q1
$74.4M Sell
806,878
-10,349
-1% -$963K 0.1% 188
2014
Q4
$77.1M Sell
817,227
-11,103
-1% -$985K 0.12% 183
2014
Q3
$66.9M Buy
828,330
+33,251
+4% +$2.74M 0.11% 186
2014
Q2
$67M Sell
795,079
-19,548
-2% -$1.6M 0.11% 182
2014
Q1
$66.4M Buy
814,627
+169,609
+26% +$13.5M 0.12% 175
2013
Q4
$48.5M Buy
645,018
+15,652
+2% +$1.14M 0.09% 215
2013
Q3
$42.8M Buy
629,366
+38,405
+6% +$2.65M 0.09% 231
2013
Q2
$38.1M Buy
+590,961
New +$39.2M 0.09% 228

Other funds holding SYK

Charles Schwab's SYK Position: Q1 2026 in Review

Charles Schwab increased its Stryker (SYK) stake by 2.2% in Q1 2026, buying an estimated $16.4M and bringing the position to 2,120,239 shares worth $697M. The position accounts for 0.11% of the portfolio, ranked #156.

Charles Schwab first reported a position in SYK in Q2 2013 and has held it in 52 quarters since. The position peaked at $805M in Q2 2025. 2,294 funds tracked by Wall St. Rank hold SYK as of Q1 2026.

  • Charles Schwab held 2,120,239 shares of Stryker worth $697M as of Q1 2026.
  • Charles Schwab bought 45,633 Stryker shares in Q1 2026, an estimated $16.4M.
  • Stryker made up 0.11% of Charles Schwab's portfolio in Q1 2026, its #156 holding.
  • Charles Schwab first reported a position in Stryker in Q2 2013 and has held it in 52 quarters since.
  • Charles Schwab's Stryker position peaked at $805M in Q2 2025.
  • 2,294 funds tracked by Wall St. Rank held Stryker as of Q1 2026.

Based on Charles Schwab's 13F filing for Q1 2026, filed 15 May 2026.